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ABSTRACT
Objectives: Antioxidant is a substance such as Vitamin C that able to remove potentially damaging oxidizing agents. Malondialdehyde (MDA) is an important 
marker of oxidative stress that have correlation with Type 2 diabetes mellitus (DM) progression. Phaseolus vulgaris L (PV) (beans) is one of the alternative 
medicines to treat DM in Indonesia. We investigated the antioxidant activity of ethanolic extract on PV (EEPV) beans using in vitro and in vivo model.
Methods: Antioxidant assay in vitro was conducted using 1,1-diphenyl-2-picrylhydrazyl (DPPH) method. Alloxan (120 mg/kg, intraperitoneally)-
induced diabetic rats were divided into 5 groups (n=5), i.e., NC: Normal control, P1: Diabetic-control, P2, P3, and P4 (200 mg/kg, 400 mg/kg, and 
600 mg/kg of EEPV, orally) for 28 days. MDA serum level was evaluated using spectrophotometer. The data were analyzed by one-way ANOVA test.
Results: The antioxidant assay in vitro showed that EEPV has very weak (IC50=641.87 µg/ml, whereas Vitamin C as standard showed very strong 
activity (IC50=2.95 µg/ml). MDA level were 2.80±0.09 nmol/ml (NC), 3.30±0.42 nmol/ml (P1), 3.27±4.23 nmol/ml (P2), 2.93±0.05 nmol/ml (P3), and 
3.17±0.25 nmol/ml (P4). There was no significant differences among normal control, diabetic-control, and EEPV-treated groups (p>0.05).
Conclusion: EEPV showed a very weak antioxidant activity in vitro.
Keywords: Antioxidant, Phaseoleus vulgaris L, Beans, Ethanolic extract, In vitro, In vivo.
INTRODUCTION
Free radicals, highly reactive, able to damage molecules, are known 
increasingly as an underlying mechanism of cells injury that affecting 
human health and disease, associated with diabetes mellitus (DM) 
Type 2 [1].
In diabetes, impaired glucose metabolism may lead to an increase in 
hydroxyl radical production. Free radicals may also be formed through 
the autoxidation of unsaturated lipids in plasma and membrane lipids. 
The free radicals product may react with polyunsaturated fatty acids in 
cell membranes leading to lipid peroxidation [2]. Thus, it will damage 
the membrane lipid bilayer structure that causes membrane-bound 
receptors and enzymes inactivation, so that the tissue permeability 
is increased. The end products of lipid peroxidation are propanal, 
hexanal,4-hydroxynonenal, and malondialdehyde (MDA) [3]. MDA is a 
highly mutagenic compound that represents the activity of free radicals 
in the cells so can be used as a biomarker of the lipid peroxidation [4-6].
Beans (Phaseolus vulgaris L. [PV]) are grain legumes, commonly used 
as cuisine, that have been consumed among people worldwide [7]. 
Conventionally, people were also use it as a herb to get its weight loss 
activity, antidiabetes, and antioxidant [8].
The previous study showed that oral administration of aqueous extract 
of PV (AEPV) (200 mg/kg body weight [BW]) for 45 days to diabetic rats 
significantly decreased the plasma thiobarbituric acid (TBA)-reactive 
substances and hydroperoxides. AEPV at 400 mg/kg BW was also 
significantly reduce (p<0.05) the values of alanine aminotransferase, 
aspartate aminotransferase, and alkaline phosphatase [8].
Many studies have shown that oxidative stress/free radical is strongly 
associated with diabetes and particularly with the complications of 
diabetes [9]. Our previous study showed the antihyperglycemic activity 
of ethanolic extract on PV (EEPV). Therefore, the current study was 
conducted to evaluate its antioxidant activity.
METHODS
Chemical and reagents
Alloxan, formalin buffer 10%, heparin sodium, sodium chloride, cell 
lysis buffer, paraffin wax, TBA reagent, aquabidest, 70% and 80% 
aqueous alcohol and 96% absolute alcohol, xylitol, glycerin, Mayer’s 
hematoxylin, eosin, Canada balsam. All other chemicals were of analytic 
grade.
Animals
Male healthy Wistar rats (Rattus norvegicus) were obtained from animal 
house of Universitas Sumatera Utara. The rats with following inclusion 
criteria were included in the study, i.e., age 2–3 months, 150–200 g BW. 
The study was conducted after approved by Animal Research Ethics 
Committees, Faculty of Mathematics and Natural Sciences (FMIPA), and 
Universitas Sumatera Utara (No. EC: 115/KEPH-FMIPA/2017).
Plant material and preparation of EEPV
The PV beans (Fig. 1) were collected at the Berastagi city, on of 
district in Medan (Sumatera Utara) (Fig. 2), in February 2017 and was 
authenticated by the Department of Botany, Universitas Sumatra Utrara. 
EEPV was done with maceration method that used ethanol solvent with 
ratio 1:10 (w/v). The dried PV was dissolved by 10 parts after that 
poured with 75 parts of ethanol 96% as the essence. Closed and left 
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for 5 days and shielded from the light while stirring occasionally. After 
5 days, the solution was filtered, the pulp was squeezed, and washed 
with enough liquid essence to obtain 100 parts. The extract was 
obtained evaporated at a temperature of 50°C.
Induction of diabetes
Alloxan solution in 0.1 M citric buffer was administered at single 
dose of 120 mg/kg BW intraperitoneally. Diabetes was confirmed 
by determining the blood glucose concentration using glucometer 
(glucoDrTM model AGM-2100), after 72 h of alloxan injection. The 
rats with blood glucose level ˃250 mg/dl were selected for the study 
[10,11].
Experimental design
The animals were divided randomly into five groups of five rats each 
and treated as follows:
1. Group I (NC): Normal control rats (standard pellets and water ad-
libitum) for 28 days.
2. Group II (P1): Diabetic control rats were administered with 
120 mg/kg of alloxan, standard pellets, and water ad libitum for 
28 days.
3. Group III (P2): Diabetic rats+EEPV at dose of 200 mg/kg BW/day 
for 28 days.
4. Group IV (P3): Diabetic rats+EEPV at dose of 400 mg/kg BW/day 
for 28 days.
5. Group V (P4): Diabetic rats+EEPV at dose of 600 mg/kg BW/day for 
28 days.
Antioxidant assay: 1,1 Diphenyl-2-picrylhydrazyl (DPPH) radical 
scavenging assay
The DPPH radical-scavenging activities of experimental autoimmune 
encephalomyelitis were determined according to Molyneux [12].
DPPH preparation
20 mg of DPPH was dissolved in methanol until 50 ml to obtain 
400 mcg/ml of DPPH solution.
Determination of maximum wavelength
As much as 5 ml of DPPH solution was put in a 50 ml of mixed flask, and the 
volume was adjusted with methanol to the mark line, to obtain a solution 
with a concentration of 40 mcg/ml. The absorbance was measured at 
400–800 nm wavelength. The spectrum obtained then was observed.
Measurement of DPPH absorbance after addition of EEPV
As much as EEPV 100 mg was dissolved in 50 ml of methanol to obtain 
2000 µg/ml (LIB). Different sample volumes of LIB (10, 12.5, 15, 17.5, 
20 ml) were put in mixed flask (50 ml)+5 ml DPPH (400 µg/ml) to 
obtain different extract concentration, i.e., 400, 500, 600, 700, 800, and 
DPPH 40 mcg/ml. After 10–30 min, the absorbance was measured at 
maximum wavelength 516.5 nm.
Measurement of DPPH absorbance after addition of Vitamin C
Vitamin C as much as 25 mg crystal was dissolved in methanol until 
100 ml, to obtain 250 µg/ml (LIB). Different volume of LIB (0.2, 0.4, 0.6, 
0.8, 1 ml) were put 50 ml mixed flask of each. 5 ml DPPH (400 µg/ml) 
was added to obtain different Vitamin C concentrations, i.e., 1, 2, 3, 4, 
5, and DPPH 40 µg/ml). The absorbance was measured at wavelength 
516.5 nm after 10–30 min.
The assay was performed in triplicate. The percentage of DPPH radical 
scavenging activity was calculated as follows






A DPPH = Absorbance of DPPH without sample
A sample = Absorbance of DPPH with sample
IC50 was determined using regression linear equation.
Measurement of MDA level
MDA level from the blood sample is determined by TBA method that 
measured using spectrophotometer at wavelength 532 nm. The 
presence of MDA is identified by the pink color formation after it reacted 
with TBA in acidic conditions. Measurement of MDA conducted at the 
Laboratory of Biochemistry Faculty of Medicine, Universitas Sumatera 
Utara. Data were analyzed using one-way ANOVA, p<0.05 considered as 
statistically significant.
RESULTS
DPPH radical scavenging assay
Tables 1-3 show the activity of EEPV and Vitamin C as radical scavengers.
The antioxidant assay in vitro showed that EEPV has very weak 
(IC50=641.87 µg/ml, whereas Vitamin C as standard showed very 
strong activity (IC50=2.95 µg/ml).
MDA level
MDA level of this study is shown in Table 4.
There was no significant differences among normal-control, diabetic-
control, and EEPV-treated groups (p>0.05).
DISCUSSION
Diabetes can be produced in animals by alloxan induced, result in 
the production of active oxygen species from an imbalance between 
radical-generating and radical-scavenging systems, i.e., increased free 
Fig. 1: Phaseolus vulgaris L
Fig. 2: Location of Berastagi
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radical production or reduced activity of antioxidant defenses or both. 
Several studies have shown that DM (Types 1 and 2) is accompanied 
by the increased formation of free radicals and decreased antioxidant 
capacity, leading to oxidative damage of cell components [13]. 
Scavengers of free radicals are effective in preventing diabetes in these 
animal models.
PV has a notable place in the folklore throughout the world and in 
the traditional usage of many cultures such as antidiabetic [14,15]. 
In Indonesia, this plant commonly grows in Karo lands, especially 
Berastagi, one of the districts in North Sumatera, Indonesia. Local 
residents also often use it to alleviate the rise of blood glucose levels.
The present study continued with antioxidant activity test using 
DPPH radical-scavenging method. This assay was used to evaluate 
the strength of antioxidant properties of EEPV compare to Vitamin C. 
Vitamin C, is a water-soluble free radical scavenger that can change 
to the ascorbate radical by donating an electron to the lipid radical 
to terminate the lipid peroxidation chain reaction [16]. The roles of 
many dietary polyphenolic constituents derived from plants are more 
effective antioxidants in vitro than Vitamins E or C, and thus might 
contribute significantly to the protective effects [17]. The more polar 
ones (ethyl acetate and n-butanol) are those that generally have higher 
antioxidant activity [18].
Tables 1-3 show the activity of EEPV and Vitamin C as radical 
scavengers. The higher of EEPV lowered the absorbance which 
means the scavenging activity of EEPV increased following the 
higher concentration of EEPV. The IC50 values showed the inhibition 
concentration of DPPH at 50%. The results showed that IC50 of EEPV 
was 641.87 µg/ml whereas Vitamin C as standard was at 2.79 µg/ml. 
A compound claimed to have antioxidant activity when the IC50 as the 
following categories: <50 µg/ml (very strong), 50–100 µg/ml (strong), 
101–150 µg/ml (moderate), and 151–200 µg/ml (weak). Therefore, 
the present study concluded that EEPV has very weak antioxidant 
properties while Vitamin C showed a very strong antioxidant activity.
In the present study, the increased levels of MDA clearly show that 
diabetic group (P1) was exposed to an increased oxidative stress 
through lipid peroxidation [19]. Decreased levels of MDA showed in P3 
(EEPV at dose of 400 mg/kg BW).
The reports about the status of antioxidants and antioxidant enzymes in 
diabetic patients are very contradictory, both increase and decrease of 
antioxidant activity have been reported [19]. Products of membrane lipid 
peroxidation and other oxidants like H2O2 may react with superoxide 
dismutase resulting in oxidative modification thereby causing loss of 
enzyme activity [20]. Furthermore, diabetic hyperglycemia leads to 
glycation and inactivation of superoxide dismutase thus attributing to 
its decrease.
CONCLUSION
EEPV showed a very weak antioxidant activity in vitro.
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